NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Lipidio Pharmaceuticals

Lipidio Pharmaceuticals

Private
San Diego, CaliforniaHealthcare & Life Scienceshttps://lipidiopharma.com/

Last Round

Series A

Extension

Nov 10, 2022

Total Funding Raised

$20M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Lipidio Pharmaceuticals is a biopharmaceutical company that develops novel therapeutics for dermatological and metabolic diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biopharmaceuticalsmall-molecule therapeuticstopical drugdermatologymetabolic diseaseclinical-stage biotechdrug developmentclinical trialsnon-alcoholic steatohepatitisNASHsebaceous hyperplasiabiotech startupdrug discoveryneuroendocrine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Lipidio Pharmaceuticals Comps

Public and private peers based on sector, stage, and business model.

Lipidio Pharmaceuticals comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Lipidio Pharmaceuticals Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionNov 10, 2022
Series AMar 3, 2020

Key People

Founding team and executive leadership

J Gordon Foulkes

CEO

Executive Team

Lipidio Pharmaceuticals Investors

Notable investors and investment history

Lipidio Pharmaceuticals investors
InvestorRounds
Foundation for Prader-Willi ResearchSeries A
Alethea Capital Management, LLCSeries A Extension, Series A
Bencao CapitalSeries A Extension, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 15, 2026

    Monthly visitors grew 102% MoM, reaching 1.5K.

  • Apr 20, 2026

    Monthly visitors grew 341% MoM.

Lipidio Pharmaceuticals Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Lipidio Pharmaceuticals Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Lipidio Pharmaceuticals's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Diego, California
Employee Range6
Year Founded2018
Last FundingNov 10, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.